Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
TSI-GSD-104 by Defender Pharmaceuticals for Eastern Equine Encephalitis: Likelihood of Approval
TSI-GSD-104 is under clinical development by Defender Pharmaceuticals and currently in Phase II for Eastern Equine Encephalitis. According to GlobalData,...